LysaKare 25 g/25 g solution for infusion, Lutathera 370 MBq/mL solution for infusion
CAAA601A32201
Phase 2 small_molecule active
Quick answer
LysaKare 25 g/25 g solution for infusion, Lutathera 370 MBq/mL solution for infusion for somatostatin receptor positive gastroenteropancreatic neuroendocrine (GEP-NET) tumors, pheochromocytoma and paragangliomas is a Phase 2 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Advanced Accelerator Applications
- Indication
- somatostatin receptor positive gastroenteropancreatic neuroendocrine (GEP-NET) tumors, pheochromocytoma and paragangliomas
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active